Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novavax Stock: Buy at the High?

TheMotleyFool

0 0

Of all the rags to riches stories that the pandemic has fueled for drugmakers, few are as incredible as Novavax (NASDAQ: NVAX). Shares are up about 2,500% from the beginning of the year. After the surge, should investors pass or should they buy at the high?

Image source: Getty Images.

Admittedly, the stock isn't near it's all-time high. Shares peaked around $180 briefly this summer, after the company became part of the U.S. government's Operation Warp Speed (OWS) and management announced positive phase 1 data from trials of its vaccine candidate.

Source Fool.com

Like: 0

NVAX

Share